What is acute myeloid leukaemia (AML)?

AML is a type of blood cancer that starts from young white blood cells in the bone marrow. Find out how common it is and who might get it.

Symptoms of acute myeloid leukaemia (AML)

Symptoms of AML can be similar to those caused by other illnesses. Find out about the possible symptoms and when to see your doctor.

Risks and causes of acute myeloid leukaemia (AML)

We don’t know what causes most cases of acute myeloid leukaemia. But there are some factors that may increase your risk of developing it. Find out what some of these are.

Types and risk groups of acute myeloid leukaemia (AML)

AML is divided into different groups (subtypes) using the World Health Organization (WHO) classification system. It is also divided into risk groups based on genetic changes and other factors. Find out more.

Getting diagnosed with acute myeloid leukaemia (AML)

Most people start by seeing their GP if they have symptoms of blood cancer such as leukaemia. Other people may go to accident and emergency (A and E) depending on their symptoms. Find out what to expect when you see a GP, when they refer you to an AML specialist and the tests you might have.

Treatment for acute myeloid leukaemia (AML)

Chemotherapy is the main treatment for acute myeloid leukaemia (AML). Find out how your doctor decides your treatment, detailed information about the each treatment, the side effects and follow up.

Research and clinical trials for acute myeloid leukaemia (AML)

Find out about the latest UK research looking at acute myeloid leukaemia (AML), as well as how you can take part.
 

Living with acute myeloid leukaemia (AML)

Get support to cope during and after acute myeloid leukaemia (AML) treatment, including information on diet, physical activity, sex, fertility and life after a transplant.

Survival for acute myeloid leukaemia (AML)

Survival for acute myeloid leukaemia (AML) depends on many factors. Find out what can affect your outllook.  

Last reviewed: 
25 Sep 2023
Next review due: 
25 Sep 2026

Page Credits: 

This section is written, reviewed and updated by Cancer Research UK’s Patient Information Web Team. Thanks to the expert medical professionals and people affected by cancer who have helped to review this information.

  • Dr Eleni Ladikou (Haematology Specialty Trainee and Honorary Lecturer in Haematology)
  • our lay reviewers